Compugen (CGEN) Accounts Payables (2009 - 2026)
Compugen (CGEN) reported Accounts Payables of $2.5 million for Q1 2026, down 76.92% on a YoY basis from $10.9 million in Q1 2025, and up 7.35% sequentially from $2.4 million in Q4 2025.
Compugen (CGEN) Accounts Payables (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Accounts Payables data on file, last reported at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 76.92% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 76.92% YoY), and the FY2025 full-year result was $2.4 million, up 28.02% from the prior year.
- Accounts Payables advanced to $2.5 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $14.5 million in Q4 2023 to a low of $1.7 million in Q2 2023.
- A 5-year average of $7.6 million and a median of $9.8 million in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 137.63% in 2022 and sank 87.31% in 2024, its largest moves.
- Tracing CGEN's Accounts Payables over 5 years: stood at $11.0 million in 2022, then jumped by 31.91% to $14.5 million in 2023, then sank by 87.31% to $1.8 million in 2024, then rose by 28.02% to $2.4 million in 2025, then gained by 7.35% to $2.5 million in 2026.
- Business Quant data shows CGEN's Accounts Payables at $2.5 million in Q1 2026, $2.4 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | 1.79 Mn |
| Mar 31, 2025 | 10.94 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 11.40 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 13.43 Mn |
| Dec 31, 2023 | 14.49 Mn |
| Sep 30, 2023 | 9.78 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 12.52 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 11.45 Mn |
| Dec 31, 2021 | 4.62 Mn |
| Sep 30, 2021 | 13.66 Mn |
| Jun 30, 2021 | 1.81 Mn |